Clinical trial Recruiting at 1 site Interventional Ages 10 to 18

Individualized exercise plan for kids with hypertrophic cardiomyopathy

Official title: Effects of Exercise Prescription on Cardiovascular Health and Quality of Life in Children With Hypertrophic Cardiomyopathy

Run by Alder Hey Children's NHS Foundation Trust · NCT07595354 · Data updated 2026-11-12

Aimed at children aged 10–18 with non-obstructive HCM, the study tests whether a personalized exercise prescription can be safely delivered and followed.

Quick facts

Study typeInterventional
Ages10 Years to 18 Years
SexAll
Enrollment10 (estimated)
SponsorAlder Hey Children's NHS Foundation Trust
Academic / other
Locations1 site (Liverpool)
StatusRecruiting
StartedDecember 24, 2025
Main results expectedMarch 2027
Study endsAugust 2027
Registry record updatedMay 19, 2026
Trial IDNCT07595354 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ages 10–18 with non-obstructive HCM under evaluation at Alder Hey, and who can maintain an exercise log with support.

Probably not a fit

Children with complex co-morbidities, mobility limitations, or those unable to participate in follow-up could see little or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates delivering a customized exercise plan created by a team of clinicians to children with hypertrophic cardiomyopathy who have normal heart function. Participants will work with doctors, nurses, and physiotherapists to develop and implement an exercise prescription and will log their activity weekly with carer support. The goal is to determine feasibility, safety, and adherence to the personalized plan. The research is conducted at Alder Hey Children’s Hospital in Liverpool and focuses on non-obstructive HCM.

Why it matters

Potential benefit: If successful, children may gain safer, tailored exercise routines that support physical health and well-being.

How similar studies have gone: Previous work suggests exercise can be feasible for many with HCM when properly supervised, though this specific individualized prescription approach is being explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Undergoing screening for HCM due to a family history or gene-positive
* Aged 10 to 18 years (inclusive)
* Known to the inherited cardiac conditions clinic at Alder Hey Children's Hospital
* Normal cardiac function
* Able to complete an exercise log weekly with support from carers
* Child or carer able to participate in telephone follow-up

Exclusion Criteria:

* Moderate to severe co-morbidities, including neuromuscular and respiratory illness and conditions affecting mobility
* Learning difficulties precluding exercise participation
* Phenotype of HCM
* History of exercise-induced arrhythmia and/or syncope
* History of unexplained syncope
* Patients with an implantable cardiac defibrillator (ICD)
* Family History of sudden cardiac death in first-degree relative
* Child or carer unable to comply with telephone follow-up

Where it's running

  • Alder Hey Children's Hospital
    Liverpool, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.